Department of Biochemistry, Children's Hospital, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.
Traffic. 2010 Jul 1;11(7):987-1000. doi: 10.1111/j.1600-0854.2010.01073.x. Epub 2010 Apr 16.
CLN7 is a polytopic lysosomal membrane protein deficient in variant late infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. In this study fluorescence protease protection assays and mutational analyses revealed the N- and C-terminal tails of CLN7 in the cytosol and two N-glycosylation sites at N371 and N376. Both partially and non-glycosylated CLN7 were correctly transported to lysosomes. To identify lysosomal targeting motifs, we generated CD4-chimera fused to the N- and C-terminal domains of CLN7. Lysosomal localization of the chimeric proteins requires a consensus acidic dileucine-based motif in the N-terminus and two tandem tyrosine-based signals in the C-terminus. Mutation of these sorting motifs resulted in cell surface redistribution of CD4 chimeras. However, the dileucine-based motif is of critical importance for lysosomal localization of the full-length CLN7 in different cell lines. Cell surface biotinylation revealed that at equilibrium 22% of total CLN7 is localized at the plasma membrane. Mutation of the dileucine motif or the co-expression of dominant-negative mutant dynamin K44A led to a further increase of CLN7 at the plasma membrane. Our data demonstrate that CLN7 contains several cytoplasmic lysosomal targeting signals of which the N-terminal dileucine-based motif is required for the predominant lysosomal targeting along the indirect pathway and clathrin-mediated endocytosis of CLN7.
CLN7 是一种多拓扑溶酶体膜蛋白,在变异型晚发性婴儿神经元蜡样脂褐质沉积症(一种神经退行性溶酶体贮积症)中缺乏。在这项研究中,荧光蛋白酶保护测定和突变分析揭示了 CLN7 的 N 端和 C 端尾部位于细胞质中,以及两个 N 端的 N371 和 N376 糖基化位点。部分和非糖基化的 CLN7 都能正确转运到溶酶体。为了鉴定溶酶体靶向基序,我们生成了 CD4 嵌合体,融合到 CLN7 的 N 端和 C 端结构域。嵌合蛋白的溶酶体定位需要 N 端的一个共识酸性双亮氨酸基序和 C 端的两个串联酪氨酸信号。这些分拣基序的突变导致 CD4 嵌合体在细胞表面的重新分布。然而,双亮氨酸基序对于不同细胞系中全长 CLN7 的溶酶体定位至关重要。细胞表面生物素化显示,在平衡状态下,总 CLN7 的 22%位于质膜上。双亮氨酸基序的突变或显性负突变 dynamin K44A 的共表达导致 CLN7 在质膜上的进一步增加。我们的数据表明,CLN7 包含几个细胞质溶酶体靶向信号,其中 N 端的双亮氨酸基序是沿着间接途径和 CLN7 的网格蛋白介导的内吞作用将 CLN7 主要靶向溶酶体所必需的。